Navigation Links
MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
Date:10/29/2007

SAN FRANCISCO, Oct. 29 /PRNewswire/ -- MedImmune today announced results from a recent economic analysis of Synagis(R) (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in high- risk infants. Released at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, the analysis evaluated the costs of providing Synagis to premature infants, as well as the potential health benefits and cost savings that could occur from lower rates of severe RSV infections.

RSV can cause severe lower respiratory tract infections in preterm infants. However, recent data have suggested that RSV infection early in an infant's life may cause subsequent chronic respiratory complications such as persistent wheezing.

Dr. Mark Polak, a neonatologist and professor of pediatrics from the West Virginia University School of Medicine and lead author of the economic analysis, noted, "We factored in the potential costs of possible future complications and the quality of life associated with persistent wheezing and, based on these assumptions, our study found that preventing RSV early in life makes economic sense."

The authors noted that more evidence is needed to substantiate the linkage between Synagis and subsequent reductions in persistent wheezing.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Foo
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... WASHINGTON , May 27, 2015 Doctors ... Innovation at Children,s National Health System ... to treat osteoid osteoma, a benign but ... young adults, using an experimental magnetic resonance-guided high-intensity focused ... and 10-year-old Niyati Shah , have been ...
(Date:5/27/2015)... 25, 2015 Research and Markets ... of the "2015 Strategies in the European ... This comprehensive five-country report contains 500 ... current suppliers and potential market entrants identify and ... testing market during the next five years. ...
(Date:5/27/2015)... DUBLIN , May 25, 2015 Research ... the "Global Rapid Medical Diagnostic Kits Market - ... Global market for Rapid Medical Diagnostic Kits, estimated ... in 2015 and further expected to maintain a CAGR ... projected US$27 billion by 2020. The global ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4European Coagulation Testing Market Strategies 2015 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4
... sleep onset, sleep maintenance ... total sleep time compared to placebo, BRIDGEWATER, N.J., June ... showed Ambien CR(R) (zolpidem,tartrate extended-release) CIV tablets 12.5 mg provided ... over 8,weeks in patients with co-morbid insomnia and major depressive ...
... of Roche and Ipsen,s First Once-Weekly Human ... Meeting -, NUTLEY, N.J., June 10 Roche ... been shown to provide,significant improvements in glucose control and ... safety and tolerability profile that,supports entry into Phase III. ...
Cached Medicine Technology:Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 2Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 3Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 4Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6
(Date:5/27/2015)... Black Book Rankings, well known ... the multiple services and software industries, conducted a ... ranked Electronic Health and Medical Record software systems ... focus on implemented EHR users, Black Book reveals ... the highest scores in client experience among small ...
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 The ... of three FDA-approved dermal filler treatments in Abilene, Texas: ... to reduce the appearance of glabellar lines, better known ... Belotero Balance® is designed to treat smoker’s lines ... to the chin, while Radiesse® improves the appearance of ...
(Date:5/27/2015)... Coco Libre announced today that artists and audiences ... Organic Coconut Water to quench their thirst during the festival ... areas, artist greenrooms, corporate skyboxes and concessions areas at the ... on festival shuttle buses. , “We’re excited to have ... Director of Strategic Partnerships for Latitude 38 Entertainment, producer of ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Genius ... of their advanced programmatic marketing technology, they have boosted ... advertising support on a regional level for seven Utah-based ... marketing was through television and radio media. In 2014 ... with the help of Genius Monkey , shifted ...
(Date:5/27/2015)... Iowa (PRWEB) May 27, 2015 With ... away, a poll conducted during the "ACA - Controlling ... poll participants, 75% are currently in the process of ... over 15% were confidently prepared for the reporting mandates. ... shown during the webinar, those who are currently vetting ...
Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... the Sept.1 issue of the journal SLEEP ... is associated with increased sleep disturbances. Associations also were ... bullying has detrimental effects even when it is experienced ... of workplace bullying, with 11 percent of women and ...
... , , , ... ), a leading provider of kidney care services for those diagnosed ... one of the nation,s leading health care industry publications, named Kent ... Most Powerful People in Healthcare in 2009. , , ...
... , , , , ... Communications, Inc. (ECI), a full-service direct marketing agency staffed with seasoned ... www.starmsgroup.com ), has appointed Robin Raff to the position of ... www.ecihealthcare.com ). Raff reports directly to ECI CEO and ...
... WASHINGTON, Aug. 31 As Congress prepares to ... in at least 102 rallies and other events in 20 ... public health insurance option. , , Events ... day Congress returns to Washington, D.C.. They are taking place ...
... , , , ... MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology ... molecular diagnostics. , , "Until now, lack of ... forcing laboratories to adopt number of alternative methods such as traditional ...
... , , VENTURA, Calif., ... to give than to receive." However, when the gift one is ... moisturizer made with more than 97 percent organic aloe vera, receiving ... , Founded by Rinaldo and Lalla Brutoco, owners of ...
Cached Medicine News:Health News:Workplace bullying is associated with sleep disturbances 2Health News:Workplace bullying is associated with sleep disturbances 3Health News:DaVita CEO Kent Thiry Honored as One of Modern Healthcare's 100 Most Powerful People in Healthcare 2Health News:ECI Hires Robin Raff as Director of Strategy 2Health News:'Let's Get it Done!' From Coast to Coast, USAction Affiliates Rally This Week for Quality, Affordable Health Care 2Health News:Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy 2Health News:It's Better to Give Than to Receive 2Health News:It's Better to Give Than to Receive 3
... The Zeus Scientific, Inc. ENA Profile-6 ... for the detection of IgG antibodies to ... in human sera. When performed according to ... autoantibody profile may aid in the diagnosis ...
Inquire...
... Microalbumin Urine Controls are supplied ... liquid requiring no reconstitution or ... human urine, fortified to target ... creatinine. Preservatives including sodium azide ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: